Photopsias during Systemic Bevacizumab Therapy

Background. The authors describe a case of recurrent photopsias in a 56-year-old woman following repeat treatments with systemic intravenous bevacizumab for stage IV ovarian cancer. To our knowledge, this is the first report of photopsias following systemic bevacizumab treatments in a patient with a...

Full description

Saved in:
Bibliographic Details
Main Authors: Heather Leisy, Meleha Ahmad, R. Theodore Smith
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Ophthalmological Medicine
Online Access:http://dx.doi.org/10.1155/2016/1926178
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565199421308928
author Heather Leisy
Meleha Ahmad
R. Theodore Smith
author_facet Heather Leisy
Meleha Ahmad
R. Theodore Smith
author_sort Heather Leisy
collection DOAJ
description Background. The authors describe a case of recurrent photopsias in a 56-year-old woman following repeat treatments with systemic intravenous bevacizumab for stage IV ovarian cancer. To our knowledge, this is the first report of photopsias following systemic bevacizumab treatments in a patient with a normal eye exam. Case Presentation. A 56-year-old Caucasian female complained of onset of floaters and flashes in the temporal peripheral field of the right eye 1 day after receiving intravenous of 30 g of 25 mg/mL of systemic bevacizumab for treatment of stage IV ovarian cancer. Ophthalmic examination, including dilated fundus exam, spectral domain optical coherence tomography (SD-OCT) of the optic nerve head, and enhanced depth imaging SD-OCT of the macula, revealed no significant abnormalities. Possible mechanisms are reviewed. Conclusion. We propose that patients who undergo intravenous bevacizumab treatments are questioned for any ocular symptoms and that more systematic evaluations of retinal nerve fiber layer and choroidal effects are obtained in those patients who are on long-term treatment at high doses.
format Article
id doaj-art-c290f4e1eb1549a39621921df39c318c
institution Kabale University
issn 2090-6722
2090-6730
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Ophthalmological Medicine
spelling doaj-art-c290f4e1eb1549a39621921df39c318c2025-02-03T01:09:07ZengWileyCase Reports in Ophthalmological Medicine2090-67222090-67302016-01-01201610.1155/2016/19261781926178Photopsias during Systemic Bevacizumab TherapyHeather Leisy0Meleha Ahmad1R. Theodore Smith2Department of Ophthalmology, New York University School of Medicine, New York, NY 10016, USADepartment of Ophthalmology, New York University School of Medicine, New York, NY 10016, USADepartment of Ophthalmology, New York University School of Medicine, New York, NY 10016, USABackground. The authors describe a case of recurrent photopsias in a 56-year-old woman following repeat treatments with systemic intravenous bevacizumab for stage IV ovarian cancer. To our knowledge, this is the first report of photopsias following systemic bevacizumab treatments in a patient with a normal eye exam. Case Presentation. A 56-year-old Caucasian female complained of onset of floaters and flashes in the temporal peripheral field of the right eye 1 day after receiving intravenous of 30 g of 25 mg/mL of systemic bevacizumab for treatment of stage IV ovarian cancer. Ophthalmic examination, including dilated fundus exam, spectral domain optical coherence tomography (SD-OCT) of the optic nerve head, and enhanced depth imaging SD-OCT of the macula, revealed no significant abnormalities. Possible mechanisms are reviewed. Conclusion. We propose that patients who undergo intravenous bevacizumab treatments are questioned for any ocular symptoms and that more systematic evaluations of retinal nerve fiber layer and choroidal effects are obtained in those patients who are on long-term treatment at high doses.http://dx.doi.org/10.1155/2016/1926178
spellingShingle Heather Leisy
Meleha Ahmad
R. Theodore Smith
Photopsias during Systemic Bevacizumab Therapy
Case Reports in Ophthalmological Medicine
title Photopsias during Systemic Bevacizumab Therapy
title_full Photopsias during Systemic Bevacizumab Therapy
title_fullStr Photopsias during Systemic Bevacizumab Therapy
title_full_unstemmed Photopsias during Systemic Bevacizumab Therapy
title_short Photopsias during Systemic Bevacizumab Therapy
title_sort photopsias during systemic bevacizumab therapy
url http://dx.doi.org/10.1155/2016/1926178
work_keys_str_mv AT heatherleisy photopsiasduringsystemicbevacizumabtherapy
AT melehaahmad photopsiasduringsystemicbevacizumabtherapy
AT rtheodoresmith photopsiasduringsystemicbevacizumabtherapy